Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.

Journal of neuropathology and experimental neurology - 1 Aug 2008

Sidman Richard L, Taksir Tatyana, Fidler Jonathan, Zhao Michael, Dodge James C, Passini Marco A, Raben Nina, Thurberg Beth L, Cheng Seng H, Shihabuddin Lamya S

Abstract excerpt

Pompe disease (glycogen storage disease II) is caused by mutations in the acid alpha-glucosidase gene. The most common form is rapidly progressive with glycogen storage, particularly in muscle, which leads to profound weakness, cardiac failure, and death by the age of 2 years. Although usually co...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Glucosidases
Share to Central Nervous System
Share to Glial Fibrillary Acidic Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycogen

Share to Glycogen Storage Disease Type II

Share to Muscle Strength

Share to Psychomotor Performance

Share to Reaction Time

Source

Open in PubMed Open full text

Identifiers

PMID: 18648322
DOI: 10.1097/NEN.0b013e3181815994
PMCID: PMC2743262

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18648322-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice.PMID 18648322Read ↗

Peripheral nerve and neuromuscular junction pathology in Pompe diseaseSemantic proximity Read ↗

Longitudinal characterization of Gaac.1826dupA mice reveals the cardiac, myopathic and biochemical phenotypes of Pompe disease.Semantic proximity Read ↗

Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapySemantic proximity Read ↗

Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II.Semantic proximity Read ↗

Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsSemantic proximity Read ↗

Transcriptome assessment of the Pompe (<i>Gaa</i><sup><i>−/−</i></sup>) mouse spinal cord indicates widespread neuropathologySemantic proximity Read ↗

Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolismSemantic proximity Read ↗

The emerging phenotype of late-onset Pompe disease: A systematic literature review.Semantic proximity Read ↗

Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe diseaseSemantic proximity Read ↗

The Respiratory Phenotype of Pompe Disease Mouse Models.Semantic proximity Read ↗

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase.Semantic proximity Read ↗

Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.